
Dermatology firm Leo Pharma is closing between 100 and 150 jobs in its research and development unit, which currently counts around 1,000 employees.
”We want to focus on the R&D organization,” says Jörg Möller, head of global research and development at Leo Pharma, to MedWatch.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app